Bronchial Asthma, Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease
Conditions
Brief summary
Current diagnostic tools used in pulmonary disease often do not meet the challenges set by the respective pathophysiology. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and therapeutic monitoring of patients with various pulmonary diseases.
Interventions
ultra-low-dose qCT
Sponsors
Study design
Eligibility
Inclusion criteria
* known or suspected pulmonary lung disease * indication for computed tomography
Exclusion criteria
* pregnancy * inability to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| correlation of lung clearance index (LCI) as determined by multiple breath washout with emphysema quantification as determined by qCT | 2 weeks |
| correlation of airway resistance and reactance (R5, X5, R-D5-20) as determined by impulse oscillometry with emphysema quantification as determined by qCT | 2 weeks |
| correlation of residual volume and airway resistance as determined by body plethysmography with and emphysema quantification as determined by qCT | 2 weeks |
Countries
Germany